Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"

NCT00889967 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Cystic Fibrosis Bronchiectasis

Interventions

DRUG: Ciprofloxacin for Inhalation
DRUG: Ciprofloxacin for Inhalation
DRUG: Placebo

Sponsor

Aradigm Corporation